Page last updated: 2024-08-17

histidine and B-Cell Lymphoma

histidine has been researched along with B-Cell Lymphoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, T; Chorev, M; Ge, X; Huang, Y; Liu, F; Liu, H; Qin, X; Su, S; Sun, X; Wang, C; Wang, X; Wu, L; Xu, T	1

Other Studies

1 other study(ies) available for histidine and B-Cell Lymphoma

Article	Year
Removal of the tag from His-tagged ILYd4, a human CD59 inhibitor, significantly improves its physical properties and its activity. Current pharmaceutical design, 2012, Volume: 18, Issue:27 Topics: Amino Acid Sequence; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Bacteriocins; CD59 Antigens; Chemotherapy, Adjuvant; Drug Design; Drug Resistance, Neoplasm; Drug Stability; Histidine; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, B-Cell; Rituximab; Solubility	2012

Article

Year

Removal of the tag from His-tagged ILYd4, a human CD59 inhibitor, significantly improves its physical properties and its activity.

Current pharmaceutical design, 2012, Volume: 18, Issue:27

Topics: Amino Acid Sequence; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Bacteriocins; CD59 Antigens; Chemotherapy, Adjuvant; Drug Design; Drug Resistance, Neoplasm; Drug Stability; Histidine; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, B-Cell; Rituximab; Solubility

2012